NCT05569278View on ClinicalTrials.gov

Safety and Pharmacokinetics of GEH200486 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 22, 2022

Primary Completion Date

November 29, 2022

Study Completion Date

November 29, 2022

Conditions
Pharmacokinetics
Interventions
DRUG

GE200486 0.5M Injection

Single administration by intravenous (IV) hand injection without dilution, followed by a 5mL saline flush

Trial Locations (1)

Unknown

Rikshospitalet, Oslo

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
lead

GE Healthcare

INDUSTRY

NCT05569278 - Safety and Pharmacokinetics of GEH200486 in Healthy Volunteers | Biotech Hunter | Biotech Hunter